CRELUX – Ismail Moarefi

Crelux routinely uses MST as an orthogonal assay for high content hit characterization. Fast assays set-up and straightforward characterization of compound affinity in solution enable us to concentrate on the most promising hits for co-crystallization with their targets and significantly speed up the drug discovery process.


 

Dr. Ismail Moarefi
Chief Scientific Officer
CRELUX
Martinsried, Germany